Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count

Disease Markers

Volumn 29, Issue 1, 2010, Pages 55-61

  Dalamaga, Maria ^a   Karmaniolas, Konstantinos ^b   Lekka, Antigoni ^b   Antonakos, George ^a   Thrasyvoulides, Apollon ^a   Papadavid, Evangelia ^a   Spanos, Nikolaos ^a   Dionyssiou Asteriou, Amalia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

diabetes; glucose; glycohemoglobin; mean platelet volume; Myelodysplastic syndrome

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLYCEMIC INDEX; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MYELODYSPLASTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

MOROCCAN PEPPER VIRUS;

EID: 77957239886     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/284041     Document Type: Article

References (23)

1. N. Papanas, G. Symeonidis, E.Maltezos, G.Mavridis, F. Karavageli, T. Vosnakidis and G. Lakasas, Mean platelet volume in patients with type 2 diabetes mellitus, Platelets 15 (2004), 475-478. (Pubitemid 39656855)
2. P.M.W. Bath, C.G. Missouris, T. Buckenham and G.A. McGregor, Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis, Clin Sci 87 (1994), 253-257. (Pubitemid 24267095)
3. P.M.W. Bath and R.J. Butterworth, Platelet size: measurement, physiology and vascular disease, Blood Coagul Fibrinolysis 7 (996), 431-436.
4. J.F. Martin, E.A. Trowbridge, G. Salmon and J. Plumb, The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane A2 production and megakaryocyte nuclear DNA concentration, Thromb Res 32 (1983), 443-460. (Pubitemid 14243216)
5. P.C. Sharpe and T. Trinick, Mean platelet volume in diabetes mellitus, Q J Med 86, (1993), 739-742. (Pubitemid 23330223)
6. L. Mazzanti and B. Mutus, Diabetesinduced alterations in platelet metabolism, Clin Biochem 30 (1997), 509-515.
7. N. KilicliCamur, R. Demirtunc, C. Konuralp, A. Eskiser and Y. Basaran, Couldmean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 11 (2005), 387-392. (Pubitemid 41224401)
8. K.M. Bowles, B.A. Warner and T.P. Baglin, Platelet mass has prognostic value in patients with myelodysplastic syndromes, Br J Haematol 135 (2006), 198-200. (Pubitemid 44401616)
9. M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, H.R. Gralnick and C. Sultan. Proposals for the classification of MDS, Br J Haematol 51 (1982), 189.
10. American Diabetes Association: diagnosis and classification of diabetes mellitus, Diabetes Care 27(1) (2004), 5-10.
11. SPSS® Base 10.0ApplicationsGuide. Chicago, IL: SPSS Inc., 1989.
12. B.C. Cronk, How to use SPSS® , A stepbystep guide to analysis and interpretation, Pyrczak Publishing, Los Angeles, 1999, pp. 39-50.
13. D. Tschoepe, P. Roesen, B. Schwippert and F.A. Gries, Platelets in Diabetes: the role in the hemostatic regulation in atherosclerosis, Semin Thromb Haemost 9 (1993), 122-128. (Pubitemid 23186843)
14. D. Tschoepe, P. Roesen, J. Esser, B. Schwippert, H.K. Nieuwenhuis, B. Kehrel and F.A. Gries, Large platelets circulate in an activated state in diabetes mellitus, Semin Thromb Haemost 17 (1991), 433-438.
15. S. Srivastava, C.S. Joshi, P.P. Sethi,A.K.Agrawal, S.K. Srivastava and P.K. Seth, Altered platelet functions in noninsulindependent diabetesmellitus (NIDDM), Thromb Res 76 (1994), 451-461. (Pubitemid 24371675)
16. C.N. Martyn, D.M. Matthews, C. PoppSnijders, J. Tucker, D.J. Ewing and B.F. Clarke, Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes, Diabetes Care 9 (1986), 36-39.
17. R.L. Jones, C. Paradise and C.M. Peterson, Platelet survival in patients with diabetes mellitus, Diabetes 30 (1981), 486-489. (Pubitemid 11023368)
18. Y. Inui, T. Suehiro, Y. Kumon and K. Hashimoto, Platelet volume and urinary prostanoid metabolites in noninsulindependent diabetes mellitus, J Atheroscler Thromb 1 (1994), 108-112.
19. E. Coban, F. Bostan and M. Ozdogan, The mean platelet volume in subjects with impaired fasting glucose, Platelets 17 (2006), 67-69. (Pubitemid 41759244)
20. A.F. List and D.F. Doll, The Myelodysplastic Syndromes, in: Wintrobe's Clinical Hematology, G.R. Lee, J. Foerster, J. Lukens, F. Paraskevas, J.P. Greer and G.M. Rodgers, eds, 10th edition, Williams and Wilkins, Baltimore, 1999, pp. 2320- 2333.
21. H. Kantarjian, F. Giles, A. List, R. Lyons, M.A. Sekeres, S. Pierce, R. Deuson and J. Leveque, The incidence and impact of thrombocytopenia in myelodysplastic syndromes, Cancer 109 (2007), 1705-1714. (Pubitemid 46668530)
22. A. Manoharan, T. Brighton, G.K. Lopez, S. Moran and P. Kyle, Platelet dysfunction in Myelodysplastic Syndromes: a clinicopathological study, Int J Hematol 76 (2002), 272-278. (Pubitemid 43020317)
23. E. Coban, G. Yazicioglu, A. Berkant Avci and F. Akcit, The mean platelet volume in patients with essential and white coat hypertension, Platelets 16 (2005), 435-438 (Pubitemid 41564341)